SCHEMBL6435135

SCHEMBL6435135

COC(=O)[C@@H](c1ccc([N+](=O)[O-])cc1)c1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
CYP1A2 P05177 1/20 0.46
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
GAA P10253 2/20 0.44
HTT P42858 2/20 0.44
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
KDM4E B2RXH2 3/20 0.43
OPRK1 P41145 3/20 0.43
LMNA P02545 2/20 0.43
MITF O75030 1/20 0.43
AGTR1 P30556 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
SLC6A3 Q01959 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ABCB11 O95342 1/20 0.41
ESR1 P03372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6432711 1.00 ALDH1A1 (0.46) ALDH1A1CYP1A2KMT2AMEN1RAB9A
SCHEMBL638444 0.83 ALDH1A1 (0.63) ALDH1A1CYP1A2KMT2AMEN1RAB9A
SCHEMBL6433589 0.83 MAPT (0.46) ALDH1A1CYP1A2KMT2AMEN1RAB9A
SCHEMBL2880324 0.82 KMT2A (0.57) ALDH1A1KMT2AMEN1HTTCNR1
SCHEMBL2874789 0.82 SLC6A3 (0.52) ALDH1A1KMT2AMEN1NPC1GAA
Hydrochloric Acid SCHEMBL31522191 0.81 ALDH1A1 (0.50) ALDH1A1CYP1A2KMT2AMEN1RAB9A
Hydrochloric Acid SCHEMBL29221336 0.80 ALDH1A1 (0.49) ALDH1A1CYP1A2KMT2AMEN1RAB9A
SCHEMBL5205156 0.76 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1RAB9ANPC1
SCHEMBL6431539 0.75 ALDH1A1 (0.44) ALDH1A1CYP1A2KMT2AMEN1GAA
SCHEMBL6431542 0.75 ALDH1A1 (0.44) ALDH1A1CYP1A2KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224163-B1 USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-03-30 EP disclosed
US-6548522-B1 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide HOFFMANN-LA ROCHE INC. 2003-04-15 US disclosed
EP-1224163-A1 USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001027070-A1 USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-19 WO disclosed